Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Mikolow

12 clinical trials in Mikolow, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Mikolow at a glance
12
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

12 trials in Mikolow

Open in trial search

Psoriasis

Recruiting

Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of SPN-817 (Huperzine A) in Adults with Focal Onset Seizures: Testing Safety and Effectiveness of Treatment

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Huperzine A
  • Sponsor:Supernus Pharmaceuticals Inc.

Dermatitis atopic

Not yet recruiting

Study of the safety and effectiveness of TRIV-573 injections in adults with moderate to severe atopic dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Triveni Bio Inc.

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Desoximetasone
  • Sponsor:Medac Gesellschaft fuer klinische Spezialpraeparate mbH

Study on the Effects of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:EVO756 potassium
  • Sponsor:Evommune Inc.

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of Lunsekimig (SAR443765) for Adults with Moderate to Severe Atopic Dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of 0.1% Mometasone Furoate Emulsion and Ecural Cream for Adults with Plaque Psoriasis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Mometasone Furoate
  • Sponsor:GALENpharma GmbH

Acne

Not recruiting

Study of N-Acetyl-GED-0507-34-LEVO gel 5% applied daily for treating acne vulgaris

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:(S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid
  • Sponsor:PPM Services S.A.

Acne

Not recruiting

Title: Long-term safety study of N-Acetyl-GED-0507-34-LEVO gel 5% applied to the skin for patients with acne vulgaris

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:(S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid
  • Sponsor:PPM Services S.A.

Conjunctivitis allergic+1

Not recruiting

Study on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
  • Sponsor:CCDRD Cooperative Clinical Drug Research and Development AG

Hand dermatitis

Not recruiting

Study on Abrocitinib for Patients with Moderate to Severe Chronic Hand Eczema Unresponsive to Corticosteroids

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abrocitinib
  • Sponsor:Innovaderm Research Inc.

Dermatitis atopic

Not recruiting

Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha
  • Sponsor:Leo Pharma A/S

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Mikolow

What the registry says about research in the country

01 Dermatological Conditions

Innovative research focusing on atopic dermatitis treatments, evaluating multiple therapeutic approaches including novel biologics and traditional medications.

  • Moderate to severe atopic dermatitis studies
  • Subcutaneous treatment evaluations
  • Comparative efficacy assessments

Multiple trials examining various dosing regimens and their impact on skin lesions and disease severity.

02 Skin Disorders

Comprehensive research into chronic hand eczema and acne vulgaris, testing new topical treatments and long-term therapeutic solutions.

  • Novel topical medications
  • Long-term safety studies
  • Vehicle-controlled trials

Focus on developing safe and effective treatments for common dermatological conditions affecting quality of life.

03 Allergic Conditions

Advanced research in allergic rhinitis and associated conditions, investigating innovative immunotherapy approaches.

  • Birch pollen allergies
  • Rhinoconjunctivitis treatments
  • Subcutaneous immunotherapy

Trials focusing on specialized allergoid treatments and their clinical impact on seasonal allergies.

04 Inflammatory Skin Disease

Targeted research examining plaque psoriasis treatments, comparing various topical formulations and their effectiveness.

  • Topical corticosteroid studies
  • Comparative efficacy trials
  • Treatment optimization research

Investigation of new formulations and their impact on chronic stable plaque-type psoriasis symptoms.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.